The Independent - Amgen Science says a "breakthrough" drug improves lung cancer survival rates by 58%. The company says the results are "unprecedented".
The Independent - Amgen Science says a "breakthrough" drug improves lung cancer survival rates by 58%. The company says the results are "unprecedented".